FDA Grants Breakthrough Therapy Tag to LLY’s Ovarian Cancer Candidate
Eli Lilly and Company LLY announced that the FDA has granted a Breakthrough Therapy designation to its novel folate receptor alpha (FRα) antibody-drug conjugate (ADC),...
This fentanyl treatment is a breakthrough of hope — for anyone...
Candra Jordan had used fentanyl for years in San Francisco when she got her first injection of extended-release buprenorphine, a nascent kind of medication...
FDA Grants Breakthrough Therapy Designation to Sofi-Cel for R/R T-ALL/LBL |...
The FDA has granted breakthrough therapy designation (BTD) to soficabtagene geleucel (sofi-cel; WU-CART-007) for the treatment of relapsed or refractory (R/R) T cell...
FDA Grants Breakthrough Therapy Designation to Sofetabart Mipitecan in PROC
The FDA has granted breakthrough therapy designation to sofetabart mipitecan (LY4170156), a novel folate receptor alpha (FRα) antibody-drug conjugate, for the treatment of...
Breakthrough Trials: How AI Immunotherapies Are Accelerating Personalized Cancer Care –...
Breakthrough Trials: How AI Immunotherapies Are Accelerating Personalized Cancer Care - BlackDoctor.org - Where Wellness & Culture Connect
...
Quoin Pharmaceuticals Files for Breakthrough Designation for QRX003, Potential First Treatment...
Written by Emily J. Thompson, Senior Investment AnalystSource: GlobenewswireUpdated: 33m ago0minsSource: Globenewswire
Breakthrough Application: Quoin Pharmaceuticals has filed for Breakthrough Medicine Designation for QRX003 with...
FDA Makes Ianalumab a Breakthrough Therapy for Sjögren Disease
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation.
Source link